B. Metzler seel. Sohn & Co’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,103
| Closed | -$935K | – | 771 |
|
|
2024
Q3 | $935K | Hold |
16,103
| – | – | 0.01% | 557 |
|
|
2024
Q2 | $736K | Hold |
16,103
| – | – | 0.01% | 581 |
|
|
2024
Q1 | $1.07M | Hold |
16,103
| – | – | 0.01% | 513 |
|
|
2023
Q4 | $640K | Buy |
16,103
+1,952
| +14% | +$77.6K | 0.01% | 574 |
|
|
2023
Q3 | $451K | Sell |
14,151
-12,105
| -46% | -$386K | 0.01% | 593 |
|
|
2023
Q2 | $1.05M | Buy |
26,256
+13,940
| +113% | +$560K | 0.01% | 481 |
|
|
2023
Q1 | $526K | Buy |
12,316
+890
| +8% | +$38K | 0.01% | 548 |
|
|
2022
Q4 | $549K | Buy |
+11,426
| New | +$549K | 0.01% | 540 |
|